enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Rivaroxaban - Wikipedia

   en.wikipedia.org/wiki/Rivaroxaban

   Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]

3. Direct factor Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

   Prior to the introduction of direct factor Xa inhibitors, vitamin K antagonists such as warfarin were the only oral anticoagulants for over 60 years, and together with heparin have been the main blood thinners in use. People admitted to hospital requiring blood thinning were started on an infusion of heparin infusion, which thinned blood ...

4. Deep vein thrombosis - Wikipedia

   en.wikipedia.org/wiki/Deep_vein_thrombosis

   Using blood thinners is the standard treatment. Typical medications include rivaroxaban, apixaban, and warfarin. Beginning warfarin treatment requires an additional non-oral anticoagulant, often injections of heparin. [17] [18] [19] Prevention of VTE for the general population includes avoiding obesity and maintaining an active lifestyle.

5. Bayer's Blood Thinner Xarelto Fails in Line Extension Studies

   www.aol.com/news/bayer-apos-blood-thinner...

   For premium support please call: 800-290-4726 more ways to reach us

6. Bayer's patent for blood thinner Xarelto invalid, UK ... - AOL

   www.aol.com/news/bayers-patent-blood-thinner...

   Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto drug generated ...

7. J&J, Bayer Fail to Gain FDA Approval for Blood Thinner - AOL

   www.aol.com/2013/03/05/jj-bayer-fail-to-gain-fda...

   The U.S. Food and Drug Administration (FDA) last night rejected an application from Johnson & Johnson (NYSE: JNJ) and Germany's Bayer A.G. to extend the use of the two companies' blood thinning ...

8. Warfarin - Wikipedia

   en.wikipedia.org/wiki/Warfarin

   While the drug is described as a "blood thinner", it does not reduce viscosity but rather prevents blood clots from forming (coagulating). Accordingly, it is commonly used to prevent deep vein thrombosis and pulmonary embolism , and to protect against stroke in people who have atrial fibrillation , valvular heart disease , or artificial heart ...

9. Johnson & Johnson's Xarelto Loss is AstraZeneca PLC (ADR)'s Gain

   www.aol.com/2014/02/21/johnson-johnsons-xarelto...

   About 3 years ago, partners Bristol-Myers Squibb , and Pfizer halted an acute coronary syndrome (ACS) trial with blood thinner Eliquis due to increased bleeding Johnson & Johnson's Xarelto Loss is ...